tm logo
RADELUMIN
ADVERTISED

on 02 Oct 2024

Last Applicant/ Owned by

ABX ADVANCED BIOCHEMICAL COMPOUNDS -BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH

Heinrich-Gläser-Straße 10-1401454 Radeberg

DE

Serial Number

2205896 filed on 31st Mar 2022

Correspondent Address

(MARTINEAU IP)1440 STE-CATHERINE OUESTSUITE 330MONTREAL

QUÉBEC

CA

H3G1R8

RADELUMIN

Trademark usage description

pharmaceutical and veterinary products for the diagnosis of diseases of the prostate; pharmaceutical and veterinary products for the treatment of dise Read More

Classification Information


Class [005]
Pharmaceutical and veterinary products for the diagnosis of diseases of the prostate; pharmaceutical and veterinary products for the treatment of diseases of the prostate; pharmaceutical and veterinary products for the diagnosis of cancer; pharmaceutical and veterinary products for the treatment of cancer; medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and products for medical or veterinary purposes for the diagnosis of diseases of the prostate, containing a radiopharmaceutical compound; dietetic foods and products for medical or veterinary purposes for the treatment of diseases of the prostate, containing a radiopharmaceutical compound; dietetic foods and products for medical or veterinary purposes for the diagnosis of cancer, containing a radiopharmaceutical compound; dietetic foods and products for medical or veterinary purposes for the treatment of cancer, containing a radiopharmaceutical compound; nutritional supplements for the diagnosis of diseases of the prostate; nutritional supplements for the treatment of diseases of the prostate; nutritional supplements for the diagnosis of cancer; nutritional supplements for treating cancer; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate, containing a radiopharmaceutical compound; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate, containing a radiopharmaceutical compound; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer, containing a radiopharmaceutical compound; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer, containing a radiopharmaceutical compound; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate, containing a radiopharmaceutical compound; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate, containing a radiopharmaceutical compound; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer, containing a radiopharmaceutical compound; biological preparations for medical or pharmaceutical purposes for the treatment of cancer, containing a radiopharmaceutical compound; preparations for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes relating to the diagnosis of cancer; diagnostic preparations and materials for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; diagnostic preparations and materials for use in medical diagnostic processes relating to the diagnosis of cancer.


Classification kind code

11

Mark Details


Serial Number

2205896

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 21st Sep 2023
Agent Changed
Submitted for opposition 256
on 26th Jun 2023
Notification of Possible Opposition Sent
Submitted for opposition 22
on 09th Jun 2023
Search Recorded
Submitted for opposition 20
on 09th Jun 2023
Examiner's First Report
Submitted for opposition 223
on 09th Jun 2023
Total Provisional Refusal
Submitted for opposition 257
on 25th Aug 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 24th Aug 2022
Created
Submitted for opposition 31
on 24th Aug 2022
Formalized
Submitted for opposition 30
on 31st Mar 2022
Filed
Submitted for opposition 228
on 31st Mar 2022
International Registration